Skip to main content
European Commission logo
IP Helpdesk
  • News article
  • 4 August 2024
  • European Innovation Council and SMEs Executive Agency
  • 1 min read

Pharma patent litigation highlights in Southeast Asia in early 2020s

As Southeast Asia grows as a manufacturing base and sales market for pharmaceuticals, it is becoming more important for life sciences IP professionals to factor the region into their strategies and to monitor important legal developments across its numerous national jurisdictions. Below is a guide to the most important patent-related decisions to be issued by Southeast Asian courts so far in the 2020s.

Sources

Details

Publication date
4 August 2024
Author
European Innovation Council and SMEs Executive Agency